multiple carbons. Electron impact (EI) mass spectra were
obtained at 70 eV. Mallinckrodt anhydrous methanol was used
for all “superheated MeOH” deprotection experiments. Other
chemicals and solvents were of reagent quality.
Acylation of Adenosine with Acid Anhydrides. Adenosine
(0.5 g, 1.87 mmol), pyridine (2 mL), and an excess of the acid
anhydride were heated overnight at 50 or 80 °C (oil-bath
temperature). Volatiles were evaporated in vacuo, and the
residue was chromatographed [EtOAc/hexanes (1:2) f EtOAc
and then EtOAc/MeOH (10:1)] to give quantitative yields of the
6-N,2′,3′,5′-tri-O-tetraacyladenosines, 1, and/or 6-di-N,N-2′,3′,5′-
tri-O-pentaacyladenosines, 2.
General Procedure for Methanolysis of the Peracylated
Adenosines. Compounds 1 and/or 2 (1-2 mmol) were dissolved
in MeOH (10 mL) in a 30 mL pressure vessel equipped with a
Teflon valve. The vessel was placed in an oil bath heated at 105
or 120 °C for the specified time. Volatiles were evaporated, and
the residues were dried in vacuo. Compounds 3b and 3c were
1H NMR pure (>98%). Compound 3a was purified by crystal-
lization, and 3d-f were purified by chromatography. Larger
scale methanolysis reactions required longer reaction times and/
or higher temperatures. For example, N-deacetylation of a
solution of 1a (15.0 g, 34.5 mmol) in MeOH (150 mL) in a 250
mL vessel required heating for 6 h at 110 °C.
7-N-2′,3′,5′-Tri-O-tetraacetylformycin (7a). Formycin (1.0
g, 3.75 mmol), Ac2O (2.0 mL, 2.16 g, 21.2 mmol), and pyridine
(2 mL) were stirred for 1 h at ambient temperature. Volatiles
were evaporated, and the residue was chromatographed (EtOAc)
to give 7a (1.62 g, quantitative): UV (MeOH) max 262, 295, 305
nm (ꢀ 6200, 6800, 6700); min 247, 278, 301 nm (ꢀ 5300, 4700,
6500). 1H NMR δ 2.08, 2.10, 2.14, 2.80 (4 × s, 4 × 3H), 4.29-
4.33 (m, 1H), 4.42-4.48 (m, 2H), 5.45 (d, J ) 5.4 Hz, 1H), 5.68-
5.70 (m, 1H), 5.99 (t, J ) 5.4 Hz, 1H), 6.62 (br s, 1H), 8.24 (br s,
1H), 8.44 (s, 1H); 13C NMR δ 20.45, 20.46, 20.6, 23.0, 63.5, 71.9,
72.9, 75.7, 79.8, 120.9, 146.2, 147.9, 151.6, 155.3, 169.5, 169.6,
170.5, 172.0; FAB-MS m/z 436 (M + H+); HRMS calcd for
C18H22N5O8 436.1468, found 436.1472.
(dd, J ) 3.9, 5.4 Hz, 1H), 5.74 (t, J ) 5.9 Hz, 1H), 6.45 (d, J )
3.9 Hz, 1H), 6.46 (d, J ) 5.9 Hz, 1H), 7.13 (d, J ) 3.9 Hz, 1H),
8.34 (s, 1H); 13C NMR δ 20.3, 20.5, 20.7, 63.4, 70.7, 72.8, 79.3,
85.0, 100.0, 103.6, 121.2, 150.9, 152.1, 157.0, 169.5, 160.7, 170.3;
FAB-MS m/z 415 (100%, M + Na+); HRMS calcd for C17H20N4O7-
Na 415.1230, found 415.1231. Method B. A solution of 8a (1.0
g, 2.30 mmol) in MeOH (20 mL) was heated at 105 °C for 7 h
(TLC). Compound 8 was the major product (55-60%; 1H NMR),
but other compounds were present that had lost O-acetyl groups
from the sugar moiety.
2-Acetamido-9-(2,3,5-tri-O-acetyl-â-D-ribofuranosyl)-6-
pivalamidopurine (10a). A solution of 2-acetamido-9-(2,3,5-
tri-O-acetyl-â-D-ribofuranosyl)-6-chloropurine20 (2.9 g, 6.2 mmol)
and NaN3 (2.0 g, 30.8 mmol) in DMF (60 mL) was stirred
overnight at ambient temperature. Volatiles were evaporated,
and the residue was chromatographed [hexanes/EtOAc (2:1) f
EtOAc) to give 2-acetamido-9-(2,3,5-tri-O-acetyl-â-D-ribofurano-
syl)-6-azidopurine (2.6 g, 88%). A solution of this material (2.0
g, 4.2 mol) in MeOH (40 mL) was stirred overnight under 1 atm
of H2 with Pd‚C (5%, 180 mg). The catalyst was filtered and
washed with MeOH, and volatiles were evaporated from the
combined filtrate. The residue was chromatographed [MeOH/
EtOAc (1:10)] to give 2-acetamido-9-(2,3,5-tri-O-acetyl-â-D-ribo-
furanosyl)adenine21 (10) (1.78 g, 94%) as a yellow foam. A
solution of this material (400 mg, 0.89 mmol), pyridine (2 mL),
and pivalic anhydride (1 mL) was stirred overnight at 80 °C.
Volatiles were evaporated in vacuo, and the residue was chro-
matographed [hexanes/EtOAc (2:1) f EtOAc f MeOH/EtOAc
(1:10)] to give 10a (390 mg, 83%): 1H NMR δ 1.39 (s, 9H), 2.09,
2.10, 2.16 (3 × s, 3 × 3H), 2.54 (br s, 3H), 4.37-4.51 (m, 3H),
5.74 (s, 1H), 5.90 (t, J ) 5.1 Hz, 1H), 6.12 (d, J ) 4.9 Hz, 1H),
8.04 (s, 1H), 8.48 (br s, 1H), 8.72 (br s, 1H); 13C NMR δ 20.0,
20.2, 20.4, 24.9, 26.9, 40.1, 62.8, 70.1, 72.7, 79.8, 86.2, 120.1,
140.7, 150.3, 151.9, 152.5, 169.1, 169.2, 170.0, 174.9; FAB-MS
m/z 557 (100%, M + Na+); HRMS calcd for C23H30N6O9Na
557.1972, found 557.1967.
4-N-2′,3′,5′-Tri-O-tetraacetylcytidine8,21 (11a). Cytidine
(150 mg, 0.62 mmol) was stirred with Ac2O (1 mL, 1.08 g, 10.6
mmol) and pyridine (3 mL) for 1 h at 80 °C. Volatiles were
evaporated in vacuo, and the residue was dried under vacuum
2′,3′,5′-Tri-O-acetylformycin18 (7). A solution of 7a (1.62 g,
3.72 mmol) in MeOH (40 mL) was refluxed for 3 h (TLC).
Volatiles were evaporated to dryness, and the residue was
chromatographed [EtOAc f MeOH/EtOAc (1:10)] to give 7 (1.24
g, 84%): UV (MeOH) max 229, 293 nm (ꢀ 6200, 9800); min 244
nm (ꢀ 3200). 1H NMR δ 2.05, 2.10, 2.11 (3 × s, 3 × 3H), 4.28
(dd, J ) 4.9, 12.2 Hz, 1H), 4.34-4.37 (m, 1H), 4.59 (dd, J ) 2.4,
11.7 Hz, 1H), 5.49 (d, J ) 5.9 Hz, 1H), 5.64 (t, J ) 5.4 Hz, 1H),
5.97 (t, J ) 5.6 Hz, 1H), 6.64 (br s, 3H), 8.27 (s, 1H); 13C NMR
δ 20.4 (2C), 20.7, 63.5, 71.7, 73.3, 75.7, 76.7, 79.7, 122.6 (br s),
139.5 (br s), 140.5 (br s), 150.8 (br s), 151.8, 170.06, 170.14, 171.6;
FAB-MS m/z 416 (100%, M + Na+); HRMS calcd for C16H19N5O7-
Na 416.1182, found 416.1178.
1
at 80 °C to give 11a (0.25 g, 100%): H NMR δ 2.09, 2.11, 2.16,
2.30 (4 × s, 4 × 3H), 4.39-4.44 (m, 3H), 5.33 (t, J ) 5.9 Hz,
1H), 5.45 (dd, J ) 4.4, 5.5 Hz, 1H), 6.09 (d, J ) 3.9 Hz, 1H),
7.51 (d, J ) 7.8 Hz, 1H), 7.93 (d, J ) 7.3 Hz, 1H), 10.26 (s, 1H);
13C NMR δ 20.24 (2C), 20.6, 24.6, 62.5, 69.4, 73.5, 79.6, 89.1,
97.2, 144.0, 154.6, 163.3, 169.2, 169.3, 170.0, 171.3; FAB-MS m/z
434 (100%, M + Na+); HRMS calcd for C17H21N3O9Na 434.1175,
found 434.1178.
2′,3′,5′-Tri-O-acetylcytidine9,21 (12a). A solution of 11a (250
mg, 0.62 mmol) in MeOH (6 mL) was heated at 105 °C for 3 h.
Volatiles were evaporated, and the residue [82% (1H NMR) of
12a plus other compounds with loss of O-acetyl groups from the
sugar moiety] was chromatographed [EtOAc f MeOH/EtOAc
(1:5)] to give 12a (61%): 1H NMR δ 2.09, 2.10, 2.13 (3 × s, 3 ×
3H), 4.29-4.41 (m, 3H), 5.40 (t, J ) 5.6 Hz, 1H), 5.46 (dd, J )
4.9, 5.9 Hz, 1H), 5.92 (d, J ) 4.4 Hz, 1H), 5.96 (d, J ) 7.8 Hz,
4-N-2′,3′,5′-Tri-O-tetraacetyltubercidin19 (8a). Tubercidin
(1.0 g, 3.76 mmol), Ac2O (2.0 mL, 2.16 g, 21.2 mmol), and
pyridine (3 mL) were stirred for 2 h at 50 °C. Volatiles were
evaporated, and the residue was chromatographed (EtOAc) to
give 8a (1.48 g, 91%): 1H NMR δ 2.06 (s, 3H), 2.16 (s, 6H), 2.35
(br s, 3H), 4.35-4.45 (m, 3H), 5.59 (t, J ) 4.9 Hz, 1H), 5.79 (t,
J ) 5.9 Hz, 1H), 6.55 (d, J ) 5.9 Hz, 1H), 7.03 (d, J ) 3.4 Hz,
1H), 7.34 (d, J ) 5.9 Hz, 1H), 8.58 (s, 1H), 10.30 (br s, 1H); 13C
NMR δ 20.2, 20.4, 20.6, 24.2, 63.2, 70.6, 72.8, 79.4, 85.1, 105.0,
109.1, 123.1, 150.3, 150.5, 153.0, 169.1 (br s), 169.2, 169.5, 170.1;
FAB-MS m/z 457 (100%, M + Na+); HRMS calcd for C19H22N4O8-
Na 457.1335, found 457.1341.
2′,3′,5′-Tri-O-acetyltubercidin (8): Method A. Tubercidin
(1.0 g, 3.76 mmol), Ac2O (2.0 mL, 2.16 g, 21.2 mmol), and
pyridine (3 mL) were stirred for 1 h at ambient temperature.
Volatiles were evaporated, and the residue was chromato-
graphed (EtOAc) to give 8 (1.31 g, 89%): 1H NMR δ 2.05, 2.147,
2.151 (3 × s, 3 × 3H), 4.32-4.41 (m, 3H), 5.38 (br s, 2H), 5.56
1H), 6.49 (br s, 1H), 7.40 (d, J ) 7.3 Hz, 1H), 8.14 (br s, 1H); 13
C
NMR δ 20.38, 20.40, 20.7, 62.9, 69.8, 73.3, 78.9, 90.1, 96.2, 140.9,
155.6, 166.2, 169.5, 169.6, 170.4; FAB-MS m/z 392 (100%, M +
Na+); HMRS calcd for C15H19N3O8Na 392.1070, found 392.1086.
Acknowledgment. We gratefully acknowledge NIH
Grant GM029332, pharmaceutical company gift funds
(M.J.R.), and Brigham Young University for support of
this research.
Supporting Information Available: Experimental pro-
cedures, spectral data, and 13C NMR spectra. This material is
JO051256W
(18) Buchanan, J. G.; Stobie, A.; Wightman, R. H. Can. J. Chem.
1980, 58, 2624-2627.
(19) Wiley, P. F.; Johnson, J. H.; Hanze A. R. J. Antibiotics 1976,
29, 720-727. The site of N-acetylation (N4) and signal integration
(5.3-5.9 ppm range) were reported incorrectly for 8a.
(20) Kozai, S.; Yorikane, A.; Maruyama, T. Nucleosides Nucleotides
Nucleic Acids 2001, 20, 1523-1531.
(21) Saladino, R.; Mincione, E.; Crestini, C.; Mezzetti, M. Tetrahe-
dron 1996, 52, 6759-6780.
7458 J. Org. Chem., Vol. 70, No. 18, 2005